Skip to main content

Table 4 Direct medical costs

From: Compliance, persistence, costs and quality of life in young patients treated with antipsychotic drugs: results from the COMETA study

Variable description

90 days before enrolment (N = 637)

From enrolment to follow-up examination 1 (N = 614)

Between follow-up examinations 1 & 2 (N = 603)

Between follow-up examinations 2 & 3 (N = 587)

 

Mean €/pat-month

%

Mean €/pat-month

%

Mean €/pat-month

%

Mean €/pat-month

%

Drug treatment

115.30

29.5

144.9

35.2

146.5

34.2

144.57

35.9

Antipsychotic drugs

100.70

25.8

127.9

31.1

129.0

30.2

127.83

31.7

Concomitant drugs

14.57

3.7

16.8

4.1

17.0

4.0

16.73

4.1

Psychotherapy

114.00

29.2

108.36

26.3

98.20

22.9

93.53

23.2

Hospitalizations, of which

105.75

27.1

93.33

22.7

91.69

21.4

69.62

17.3

Full day admissions for symptom relapse

85.51

21.9

42.76

10.4

38.87

9.1

34.14

8.5

Residential Care Units

37.22

9.5

49.11

11.9

80.60

18.8

85.06

21.1

Nurse home visits

9.21

2.4

10.02

2.4

5.46

1.3

4.67

1.2

Lab and instrumental diagnostic tests

6.00

1.5

3.87

0.9

3.49

0.8

3.40

0.8

Specialist examinations

2.91

0.7

1.97

0.5

2.35

0.5

2.32

0.6

Total medical costs

390.39

100

411.61

100

428.27

100

403.17

100